|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.83 USD | +0.30% |
|
+2.96% | -3.20% |
| 12-01 | EQT Shows Interest in Vitabiotics - ET | FW |
| 11-28 | China Investment in Talks to Sell $1 Billion in US Private Equity Stakes | MT |
| Capitalization | 9.31B 8B 7.49B 6.99B 13B 836B 14.1B 87.75B 33.8B 396B 34.95B 34.21B 1,444B | P/E ratio 2025 * |
45.3x | P/E ratio 2026 * | 21.1x |
|---|---|---|---|---|---|
| Enterprise value | 10.82B 9.29B 8.69B 8.12B 15.1B 971B 16.37B 102B 39.26B 460B 40.59B 39.73B 1,678B | EV / Sales 2025 * |
5.31x | EV / Sales 2026 * | 4.35x |
| Free-Float |
24.68% | Yield 2025 * |
3.29% | Yield 2026 * | 4.08% |
Last Transcript: TPG Inc.
| 1 day | +0.30% | ||
| 1 week | +2.96% | ||
| Current month | +2.96% | ||
| 1 month | +13.89% | ||
| 3 months | +3.07% | ||
| 6 months | +25.16% | ||
| Current year | -3.20% |
| 1 week | 57.53 | 61.42 | |
| 1 month | 52.22 | 61.42 | |
| Current year | 37.52 | 70.11 | |
| 1 year | 37.52 | 71.11 | |
| 3 years | 24.74 | 72.98 | |
| 5 years | 23.09 | 72.98 | |
| 10 years | 23.09 | 72.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Winkelried
CEO | Chief Executive Officer | 65 | 31/12/2020 |
Todd Sisitsky
PSD | President | 53 | 31/12/1991 |
Jack Weingart
DFI | Director of Finance/CFO | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jim Coulter
CHM | Chairman | 65 | 11/01/2022 |
Jon Winkelried
BRD | Director/Board Member | 65 | 31/12/2020 |
Todd Sisitsky
BRD | Director/Board Member | 53 | 31/12/1991 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.30% | +2.96% | -12.79% | +92.99% | 9.29B | ||
| -0.09% | +4.46% | -18.68% | +77.77% | 119B | ||
| +1.54% | +6.29% | -18.66% | +145.80% | 113B | ||
| +0.63% | +5.51% | -6.84% | +114.65% | 35.71B | ||
| +0.91% | +5.23% | +7.28% | +78.39% | 20.11B | ||
| +0.44% | +0.15% | +13.22% | +25.57% | 16.21B | ||
| +0.48% | +1.45% | -5.34% | +9.02% | 14.9B | ||
| -0.01% | -3.10% | +21.93% | +136.65% | 12.33B | ||
| +0.56% | +2.75% | +3.30% | -15.08% | 11.99B | ||
| +2.04% | -3.85% | +58.73% | +150.00% | 10.1B | ||
| Average | +0.68% | +1.72% | +4.21% | +81.58% | 36.2B | |
| Weighted average by Cap. | +0.69% | +3.63% | -9.66% | +98.80% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.04B 1.75B 1.64B 1.53B 2.84B 183B 3.08B 19.18B 7.39B 86.52B 7.64B 7.48B 316B | 2.47B 2.12B 1.99B 1.86B 3.45B 222B 3.74B 23.29B 8.97B 105B 9.28B 9.08B 383B |
| Net income | 349M 300M 280M 262M 487M 31.31B 528M 3.29B 1.27B 14.82B 1.31B 1.28B 54.09B | 474M 407M 381M 355M 661M 42.52B 717M 4.46B 1.72B 20.13B 1.78B 1.74B 73.45B |
| Net Debt | 1.5B 1.29B 1.21B 1.13B 2.1B 135B 2.28B 14.17B 5.46B 63.93B 5.64B 5.52B 233B | 1.44B 1.24B 1.16B 1.08B 2.01B 129B 2.18B 13.55B 5.22B 61.11B 5.4B 5.28B 223B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/12/25 | 60.65 $ | +4.01% | 1,168,557 |
| 02/12/25 | 58.31 $ | +0.41% | 942,646 |
| 01/12/25 | 58.07 $ | -1.71% | 2,971,907 |
| 28/11/25 | 59.08 $ | +1.56% | 718,865 |
| 26/11/25 | 58.17 $ | +1.25% | 1,097,948 |
Delayed Quote Nasdaq, December 04, 2025 at 09:00 pm
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TPG Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
















